The GCAM plans to open four more blood centers within this year.
Green Cross(www.greencross.com), a biopharmaceutical company headquartered in S. Korea, said on January 8 that Green Cross America (GCAM), Green Cross’s subsidiary in the US, had opened its 6th blood center in the US on January 6. The 6th GCAM blood center, located in Twin Falls, Idaho, is cable of producing up to 50,000 liters of blood plasma annually, according to Green Cross.
With the opening of the 6th blood center, a total of six blood centers in the US will supply the GCAM with as much as 300,000 liters of high-quality blood plaza annually.
Securing a sustainable supply of source plasma is a prerequisite for producing plasma derivatives (highly pure plasma components obtained through a process known as blood plasma fractionation). Thus, with the inception of the GCAM back in 2009, Green Cross acquired two blood centers in the US and has continued to open new blood centers since then.
“The GCAM is planning to set up four more blood centers in the Midwest within this year, bringing the total number to 20 by 2017 and 30 by 2020,” said Bae Jae-hyun, CEO of the GCAM.
Meanwhile, the construction of Green Cross’s plasma derivatives plant, aimed at taking on the North American market for plasma derivatives, will begin in the first half of this year. Green Cross plans to complete the construction work in 2019 and have its products registered with Health Canada, the Federal department responsible for national public health, by then.